Cargando…
Expression profiling of miRNA-145 and miRNA-338 in serum and sputum of patients with COPD, asthma, and asthma–COPD overlap syndrome phenotype
BACKGROUND AND OBJECTIVES: A new phenotype with overlapping characteristics between asthma and chronic obstructive pulmonary disease (COPD) called asthma–COPD overlap syndrome (ACOS) is emerging among inflammation diseases. To date, there is no agreement on specific criteria to define this syndrome,...
Autores principales: | Lacedonia, Donato, Palladino, Grazia Pia, Foschino-Barbaro, Maria Pia, Scioscia, Giulia, Carpagnano, Giovanna Elisiana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5491577/ https://www.ncbi.nlm.nih.gov/pubmed/28694694 http://dx.doi.org/10.2147/COPD.S130616 |
Ejemplares similares
-
MiRNA and Exosomal miRNA as New Biomarkers Useful to Phenotyping Severe Asthma
por: Soccio, Piera, et al.
Publicado: (2023) -
Microparticles in sputum of COPD patients: a potential biomarker of the disease?
por: Lacedonia, Donato, et al.
Publicado: (2016) -
Omalizumab as add‐on therapy in a patient with severe asthma and OSA
por: Scioscia, Giulia, et al.
Publicado: (2020) -
EVs-miRNA: The New Molecular Markers for Chronic Respiratory Diseases
por: Soccio, Piera, et al.
Publicado: (2022) -
MicroRNA expression profile during different conditions of hypoxia
por: Lacedonia, Donato, et al.
Publicado: (2018)